Cartalax

Cartalax is a peptide bioregulator derived from cartilage tissue, belonging to a class of tissue-specific peptide complexes studied for their ability to selectively target the metabolic activity of specific organ systems. The mechanism of peptide bioregulators centres on their interaction with gene regulatory elements in target tissues: cartilage-derived peptide complexes are believed to modulate the expression of genes involved in chondrocyte (cartilage cell) metabolism, extracellular matrix protein synthesis (collagen type II, aggrecan, hyaluronic acid), and cartilage tissue remodelling. Unlike single-sequence synthetic peptides with defined receptor targets, peptide bioregulators are complex mixtures that exert pleiotropic effects on tissue-specific cellular function. In cartilage tissue, Cartalax is studied for its potential to upregulate chondrocyte proliferative activity and matrix protein production, supporting the maintenance and repair of articular cartilage — the smooth connective tissue that covers bone surfaces in joints. The peptide complex may also modulate the balance between matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs), promoting controlled matrix remodelling rather than the excessive degradation characteristic of osteoarthritic cartilage breakdown.